GLW enters the new week with a fresh tailwind — the stock has risen 6% in the past week and nearly 10% over the past month, sitting at $162.10 after a strong earnings-driven reaction that prompted a wave of analyst upgrades and target revisions.
The most telling signal this week is the breadth of analyst target-raising that followed the Q1 print. Every firm that moved on GLW in the past week lifted their price objective. Citi raised its target to $175 while keeping its Buy. Susquehanna went furthest, lifting to $180. Bank of America — already a bull — pushed its target to $186, also maintaining Buy. Even the more cautious voices moved: Barclays jumped its Equal-Weight target from $100 to $149, and Truist lifted its Hold target from $125 to $149. The direction of travel is unanimous. The one note of qualification came from JP Morgan, which earlier in April raised its target sharply from $115 to $175 while simultaneously downgrading from Overweight to Neutral — a signal that the valuation catch-up has done some of the work already. The consensus mean price target sits at $162.60, effectively in line with where the stock closed on Tuesday, leaving almost no headroom on the average even as bulls sit comfortably above it.
Valuation tells the same story of a stock priced for optimism. The trailing P/E has risen roughly 3 points over the past month to just under 47x. Price-to-book has pushed to nearly 10x, up almost a full turn in thirty days. Revenue grew 20% year-over-year in the most recent quarter, and EPS momentum ranks in the 71st percentile on a 30-day basis — the Street is lifting estimates. The EV/EBITDA, however, has contracted slightly over the same period. That divergence is worth noting: higher-multiple metrics are expanding while cash-flow multiples ease, a pattern that often reflects a market giving credit for growth acceleration rather than current earnings power alone.
Short interest is not the story here. At roughly 1.9% of free float — edging slightly lower over the past week — there is no meaningful pressure from the short side. The borrow market is similarly relaxed. Availability remains wide and cost to borrow, while it has more than doubled over the past week to 0.53%, remains trivially cheap in absolute terms. The ORTEX short score sits at a benign 29.6, well below any level that would signal crowding or squeeze dynamics. Options positioning is equally quiet. The put/call ratio, at 0.71, is essentially in line with its 20-day average of 0.705. There is no defensive hedging, no aggressive directional bet — the options market is simply watching.
The institutional register reflects the blue-chip stability of the name. Vanguard holds 11.5% of shares and added modestly in the latest period. BlackRock added nearly 900,000 shares through April. The more eye-catching move is Capital Research and Management, which added over 5.8 million shares in the quarter, and FMR (Fidelity), which added nearly 6.9 million. Those are meaningful additions from active managers at a time when the stock was trading well below current levels — and they have been rewarded. On the insider side, recent activity has been routine: the CFO sold roughly $5.2 million of stock in mid-April on a pre-arranged plan, and there have been smaller executive sales and award-related transactions since. Net insider activity over the past 90 days shows a positive value balance — but that largely reflects the volume of award grants rather than open-market buying conviction.
The most recent earnings print, delivered April 29, produced a modest one-day gain, capping a period that had seen a sharp sell-off on the prior reporting date in late April — the stock fell nearly 10% that day. The rebound since has been brisk. With no next earnings date visible yet, the near-term dynamic is less about catalysts and more about whether the Street's revised targets prove conservative or whether the multiple expansion has front-run the fundamental improvement. The gap between Bank of America's $186 bull case and the consensus mean sitting right at the current price is the clearest tension to track into the next quarter.
See the live data behind this article on ORTEX.
Open GLW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.